Millimeter Wave Therapy (MWT) for Analgesia After Total Knee Replacement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-03-31

Study Completion Date

2007-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study was to test whether the exposure to electromagnetic millimeter waves - Millimeter Wave Therapy (MWT) is effective for relief of acute postoperative pain in patients after elective unilateral total knee arthroplasty (TKA)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Acute Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Postoperative pain analgesia total knee arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Generator of electromagnetic millimeter waves

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with an American Society of Anesthesiologists physical status of II or III scheduled for elective TKA
* without previous opioid medication
* patients 35-80 years old able to use PCA pumps and Visual Analogue Scale for pain intensity measurement
* patients who have signed consent form

Exclusion Criteria

* pregnant or nursing females
* recidivist alcoholics
* extremely obese patients (body mass index \> 35)
* inability to operate PCA-pump.
* females with the history of unstable angina pectoris (s. Risks for participants)
* patients who are unable to understand the consent form
* systemic infection
* history of psychiatric disease
* necessity to change postoperative analgesic scheme for particular patient
* severe intercurrent disease during the course of MWT

Minimum Eligible Age

35 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hardy Edinger, Resident in Anesth

Role: PRINCIPAL_INVESTIGATOR

Anesthesiology and Intensive Care Medicine Department, Ernst Moritz Arndt University of Greifswald, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany

Greifswald, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Usichenko TI, Edinger H, Witstruck T, Pavlovic D, Zach M, Lange J, Gizhko V, Wendt M, Koch B, Lehmann C. Millimetre wave therapy for pain relief after total knee arthroplasty: a randomised controlled trial. Eur J Pain. 2008 Jul;12(5):617-23. doi: 10.1016/j.ejpain.2007.10.004. Epub 2007 Nov 26.

Reference Type RESULT

PMID: 18042413 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

III UV 11/03

Identifier Type: -

Identifier Source: org_study_id